rs139007744
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_018117.12(WDR11):āc.3450T>Gā(p.Phe1150Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00047 in 1,614,192 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00033 ( 0 hom., cov: 32)
Exomes š: 0.00048 ( 1 hom. )
Consequence
WDR11
NM_018117.12 missense
NM_018117.12 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 0.451
Genes affected
WDR11 (HGNC:13831): (WD repeat domain 11) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is located in the chromosome 10q25-26 region, which is frequently deleted in gliomas and tumors of other tissues, and is disrupted by the t(10;19) translocation rearrangement in glioblastoma cells. The gene location suggests that it is a candidate gene for the tumor suppressor locus. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.041124344).
BP6
Variant 10-120906788-T-G is Benign according to our data. Variant chr10-120906788-T-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 68842.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Benign=1, not_provided=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000335 (51/152340) while in subpopulation SAS AF= 0.000414 (2/4832). AF 95% confidence interval is 0.000218. There are 0 homozygotes in gnomad4. There are 25 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 51 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR11 | NM_018117.12 | c.3450T>G | p.Phe1150Leu | missense_variant | 28/29 | ENST00000263461.11 | NP_060587.8 | |
LOC105378519 | XR_001747609.2 | n.541-4446A>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR11 | ENST00000263461.11 | c.3450T>G | p.Phe1150Leu | missense_variant | 28/29 | 1 | NM_018117.12 | ENSP00000263461 | P1 | |
WDR11 | ENST00000497136.6 | c.*2723T>G | 3_prime_UTR_variant, NMD_transcript_variant | 25/26 | 1 | ENSP00000474595 | ||||
WDR11 | ENST00000604509.5 | n.3879T>G | non_coding_transcript_exon_variant | 15/16 | 2 | |||||
WDR11 | ENST00000605543.5 | c.*1969T>G | 3_prime_UTR_variant, NMD_transcript_variant | 21/22 | 2 | ENSP00000475076 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152222Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
51
AN:
152222
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000700 AC: 176AN: 251452Hom.: 0 AF XY: 0.000729 AC XY: 99AN XY: 135892
GnomAD3 exomes
AF:
AC:
176
AN:
251452
Hom.:
AF XY:
AC XY:
99
AN XY:
135892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000484 AC: 708AN: 1461852Hom.: 1 Cov.: 32 AF XY: 0.000503 AC XY: 366AN XY: 727220
GnomAD4 exome
AF:
AC:
708
AN:
1461852
Hom.:
Cov.:
32
AF XY:
AC XY:
366
AN XY:
727220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000335 AC: 51AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74502
GnomAD4 genome
AF:
AC:
51
AN:
152340
Hom.:
Cov.:
32
AF XY:
AC XY:
25
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
8
ExAC
AF:
AC:
69
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2Benign:4Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:3Other:1
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 18, 2024 | See Variant Classification Assertion Criteria. - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | WDR11: PP3, PS3:Supporting, BS1, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 16, 2023 | - - |
Hypogonadotropic hypogonadism 14 with or without anosmia Pathogenic:1Uncertain:1Benign:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 08, 2010 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | Aug 22, 2023 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Zotz-Klimas Genetics Lab, MVZ Zotz Klimas | Oct 30, 2023 | - - |
See cases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University Hospital Muenster | Nov 15, 2021 | ACMG categories: PP2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Benign
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of helix (P = 0.1736);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at